Improved Outcomes with Intensity Modulated Radiation Therapy Combined with Temozolomide for Newly Diagnosed Glioblastoma Multiforme
Purpose. Glioblastoma multiforme (GBM) is optimally treated by maximal debulking followed by combined chemoradiation. Intensity modulated radiation therapy (IMRT) is gaining widespread acceptance in other tumour sites, although evidence to support its use over three-dimensional conformal radiation t...
Saved in:
Main Authors: | Noel J. Aherne, Linus C. Benjamin, Patrick J. Horsley, Thomaz Silva, Shea Wilcox, Julan Amalaseelan, Patrick Dwyer, Abdul M. R. Tahir, Jacques Hill, Andrew Last, Carmen Hansen, Craig S. McLachlan, Yvonne L. Lee, Michael J. McKay, Thomas P. Shakespeare |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Neurology Research International |
Online Access: | http://dx.doi.org/10.1155/2014/945620 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019-04-01) -
Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide
by: Erkan Topkan, et al.
Published: (2022-01-01) -
Glioblastoma Multiforme Stem Cells
by: Irena Dimov, et al.
Published: (2011-01-01) -
Gene Therapy for Glioblastoma Multiforme
by: Smit Shah, et al.
Published: (2025-01-01) -
Current Trends in Targeted Therapies for Glioblastoma Multiforme
by: Fumiharu Ohka, et al.
Published: (2012-01-01)